118 related articles for article (PubMed ID: 11002244)
1. 48-mer synthetic peptide analogue of the hepatitis B virus "a" determinant induces an anti-HBs antibody response after a single injection.
Moynihan JS; D'Mello FI; Howard CR
J Med Virol; 2000 Oct; 62(2):159-66. PubMed ID: 11002244
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine.
Netter HJ; Woo WP; Tindle R; Macfarlan RI; Gowans EJ
Vaccine; 2003 Jun; 21(21-22):2692-7. PubMed ID: 12798605
[TBL] [Abstract][Full Text] [Related]
3. A novel microencapsulated peptide vaccine against hepatitis B.
Moynihan JS; Jones DH; Farrar GH; Howard CR
Vaccine; 2001 Apr; 19(23-24):3292-300. PubMed ID: 11312028
[TBL] [Abstract][Full Text] [Related]
4. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
Cooreman MP; Leroux-Roels G; Paulij WP
J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
[TBL] [Abstract][Full Text] [Related]
5. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
[TBL] [Abstract][Full Text] [Related]
6. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection.
Du DW; Jia ZS; Li GY; Zhou YY
World J Gastroenterol; 2003 Jan; 9(1):108-11. PubMed ID: 12508362
[TBL] [Abstract][Full Text] [Related]
7. Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant.
Waters JA; Kennedy M; Voet P; Hauser P; Petre J; Carman W; Thomas HC
J Clin Invest; 1992 Dec; 90(6):2543-7. PubMed ID: 1281839
[TBL] [Abstract][Full Text] [Related]
8. A hepatitis B virus variant found in the sera of immunised children induces a conformational change in the HBsAg "a" determinant.
Karthigesu VD; Allison LM; Ferguson M; Howard CR
J Med Virol; 1999 Aug; 58(4):346-52. PubMed ID: 10421400
[TBL] [Abstract][Full Text] [Related]
9. Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteins.
Hu WG; Wei J; Xia HC; Yang XX; Li F; Li GD; Wang Y; Zhang ZC
World J Gastroenterol; 2005 Apr; 11(14):2088-94. PubMed ID: 15810073
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response.
Waters JA; Brown SE; Steward MW; Howard CR; Thomas HC
Virus Res; 1992 Jan; 22(1):1-12. PubMed ID: 1371369
[TBL] [Abstract][Full Text] [Related]
11. Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions.
Steward MW; Sisley BM; Stanley C; Brown SE; Howard CR
Clin Exp Immunol; 1988 Jan; 71(1):19-25. PubMed ID: 3349646
[TBL] [Abstract][Full Text] [Related]
12. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
[TBL] [Abstract][Full Text] [Related]
13. Antigenic and immunogenic changes due to mutation of s gene of HBV.
Ge JH; Liu HM; Sun J; Zhang LZ; He J; Li YL; Liu H; Xu Y; Yu HY; Hu YP
World J Gastroenterol; 2004 Nov; 10(21):3137-40. PubMed ID: 15457559
[TBL] [Abstract][Full Text] [Related]
14. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
[TBL] [Abstract][Full Text] [Related]
15. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
[TBL] [Abstract][Full Text] [Related]
16. [Immunogenicity of single-dose HBsAg-PLGA controlled release microspheres in mice].
Feng L; Zhou XJ; Wang SC; Jiang Y; Qi XR
Yao Xue Xue Bao; 2006 Feb; 41(2):132-7. PubMed ID: 16671543
[TBL] [Abstract][Full Text] [Related]
17. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity.
Wu L; He JW; Yao X; Li HM; Wen YM
J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722
[TBL] [Abstract][Full Text] [Related]
18. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
[TBL] [Abstract][Full Text] [Related]
19. Identification of an epitope for T-cells correlated with antibody response to hepatitis B surface antigen in vaccinated humans.
Min WP; Kamikawaji N; Mineta M; Tana T; Kashiwagi S; Sasazuki T
Hum Immunol; 1996 Apr; 46(2):93-9. PubMed ID: 8727207
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of parenterally delivered plant-derived small and medium surface antigens of hepatitis B virus.
Fedorowicz-Strońska O; Kapusta J; Czyż M; Kaczmarek M; Pniewski T
Plant Cell Rep; 2016 May; 35(5):1209-12. PubMed ID: 26905723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
